ArticleOncogenesis2025
GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells.
Le Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleOncogenesis2025
Le Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.